ECE2009 Poster Presentations Thyroid (117 abstracts)
Differences in expression pattern of all-trans retinoic acid and retinoid X nuclear receptor subtypes in papillary thyroid carcinoma: a comparison with anaplastic thyroid carcinoma
Dana Macejova 1 , Slavomira Ondkova 1 , Stefan Galbavy 2 , Jan Podoba 2 , Juraj Kausitz 2 & Julius Brtko 1
1Institute of Experimental Endocrinology, Bratislava, Slovakia; 2Saint Elizabeth Institute of Oncology, Bratislava, Slovakia.
Retinoid receptors (RARs) upon a proper ligand binding act as all-trans retinoic acid-inducible transcription factors interacting as heterodimers with retinoid X receptors (RXRs). Predominantly, novel synthetic retinoid analogues acting through RARs as redifferentiation agents would be of great value in treating patients with advanced thyroid cancer.
The objective of this study was to investigate all-trans retinoic acid/9-cis retinoic acid nuclear receptor subtypes (RARalpha, RARbeta, RARgamma, RXRalpha, RXRbeta, RXRgamma) expression pattern in papillary thyroid tumour tissue of patients in order to compare it with that of anaplastic thyroid carcinoma and the intact thyroid tissue of the corresponding patients. The expression of the retinoid/rexinoid nuclear receptor subtypes has been analyzed by the RT-PCR technique.
The data has shown that papillary thyroid carcinoma of investigated patients expressed all subtypes of RARs and RXRs when compared to intact thyroid tissues of the corresponding patients that were lacking to express RXRgamma. In papillary thyroid carcinoma, expression of RXRgamma was enhanced in comparison with that of RXRalpha or RXRbeta. Expression of RXRgamma in the patient with anaplastic carcinoma was found to be lower than that of in patients with papillary carcinoma.
In conclusion, this type of diagnostic approaches enlisted into the diagnostic algorithm of patients before their possible treatment with retinoic acids or retinoid analogues might thus enhance therapeutical potentialities and bring positive results in the treatment of thyroid cancer.
Supported by the grant APVV-0120-07 and the VEGA grant 2/0022/08.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more